Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:35 PM
Ignite Modification Date:
2025-12-24 @ 3:35 PM
NCT ID:
NCT07013292
Eligibility Criteria:
Inclusion Criteria:
* Aged ≥ 16 Years
* Confirmed diagnosis of Friedreich's ataxia, genetically verified.
* Omaveloxolone therapy between February 2024 and May 2025, having receive treatment for at least 6 months.
Exclusion Criteria:
* Participants who interrupted treatment permanently before 6 months.
* Participants who did not complete the SSQ (Sydney swallow Questionnaire) at baseline and after 6 months of treatment.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT07013292
Study Brief:
Protocol Section:
NCT07013292